logo

PRFX

PainReformยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

PRFX Profile

Painreform Ltd

A clinical stage specialty pharmaceutical company focused on providing an extended period of post-surgical pain relief without the need for repeated dose administration while reducing the potential need for the use of opiates

Pharmaceutical
--
09/01/2020
NASDAQ Stock Exchange
2
12-31
Common stock
65 Yigal Alon St., Tel Aviv 6744316, Israel
--
PainReform Ltd was incorporated and started business in November 2007. The company is a clinical-stage specialty pharmaceutical company focused on the reformulation of existing therapies. The Company's proprietary drug sustained-release system extends the in vivo activity of APIs (active drug ingredients), thereby increasing the therapeutic window for patient treatment.